ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

SPRB Spruce Biosciences Inc

0.7185
0.0105 (1.48%)
Pre Mercado
Última actualización: 08:20:49
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Spruce Biosciences Inc SPRB NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.0105 1.48% 0.7185 08:20:49
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.708
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
30/4/202415:05BWSpruce Biosciences Announces Additional Poster Presentation..
22/4/202415:05BWSpruce Biosciences Announces Upcoming Poster Presentation at..
13/3/202415:08BWSpruce Biosciences Reports Full Year 2023 Financial Results..
13/3/202415:01BWSpruce Biosciences Announces Topline Results from..
07/3/202415:07EDGAR2Form SC 13D/A - General statement of acquisition of..
06/2/202415:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
30/1/202415:05BWSpruce Biosciences to Present at the Oppenheimer 34th Annual..
22/1/202407:00BWSpruce Biosciences Completes Enrollment in CAHmelia-204..
08/1/202407:00EDGAR2Form 8-K - Current report
05/1/202407:00BWSpruce Biosciences Reports Baseline Characteristics from..
04/1/202407:00BWSpruce Biosciences Provides Clinical Program Updates and..
03/1/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202319:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202319:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202318:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202315:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202315:09EDGAR2Form 8-K - Current report
13/11/202315:05BWSpruce Biosciences Reports Third Quarter 2023 Financial..
02/11/202315:05BWSpruce Biosciences to Participate in the Jefferies London..
18/10/202307:00BWSpruce Biosciences Completes Target Enrollment of..
28/8/202315:00BWSpruce Biosciences to Participate in the H.C. Wainwright..
14/8/202315:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202315:12EDGAR2Form 8-K - Current report
14/8/202315:00BWSpruce Biosciences Reports Second Quarter 2023 Financial..
05/7/202317:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202317:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202315:00BWSpruce Biosciences Announces Acceptance of Abstract for..
25/5/202307:00BWSpruce Biosciences Appoints Percival Barretto-Ko to Board of..
24/5/202315:05BWSpruce Biosciences to Participate in the Jefferies..
22/5/202308:30BWSpruce Biosciences Honored at CARES Foundation 15th Annual..
15/5/202307:00BWSpruce Biosciences Reports First Quarter 2023 Financial..
04/5/202315:05BWSpruce Biosciences to Present Findings on Retrospective..
02/5/202315:05BWSpruce Biosciences to Participate in May Investor..

Su Consulta Reciente

Delayed Upgrade Clock